Anne C. Hesp

433 total citations
9 papers, 297 citations indexed

About

Anne C. Hesp is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Nephrology. According to data from OpenAlex, Anne C. Hesp has authored 9 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Surgery and 4 papers in Nephrology. Recurrent topics in Anne C. Hesp's work include Diabetes Treatment and Management (6 papers), Chronic Kidney Disease and Diabetes (4 papers) and Pancreatic function and diabetes (4 papers). Anne C. Hesp is often cited by papers focused on Diabetes Treatment and Management (6 papers), Chronic Kidney Disease and Diabetes (4 papers) and Pancreatic function and diabetes (4 papers). Anne C. Hesp collaborates with scholars based in Netherlands, United States and Sweden. Anne C. Hesp's co-authors include Daniël H. van Raalte, Gozewijn D. Laverman, Jennifer A. Schaub, Pottumarthi V. Prasad, Petter Bjornstad, Volker Vallon, Hiddo J.L. Heerspink, Cecilia Karlsson, Peter J. Greasley and Marcel H.A. Muskiet and has published in prestigious journals such as Diabetes Care, Kidney International and Journal of Nutrition.

In The Last Decade

Anne C. Hesp

7 papers receiving 295 citations

Peers

Countries citing papers authored by Anne C. Hesp

Since Specialization

Citations

This map shows the geographic impact of Anne C. Hesp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne C. Hesp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne C. Hesp more than expected).

Fields of papers citing papers by Anne C. Hesp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne C. Hesp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne C. Hesp. The network helps show where Anne C. Hesp may publish in the future.

Co-authorship network of co-authors of Anne C. Hesp

This figure shows the co-authorship network connecting the top 25 collaborators of Anne C. Hesp. A scholar is included among the top collaborators of Anne C. Hesp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne C. Hesp. Anne C. Hesp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	The systemic and kidney hemodynamic response to empagliflozin, losartan and their combination varies between individuals 2025 ·Journal of Nephrology ·(unknown), (unknown), (unknown), Anne C. Hesp, Mark M. Smits, (unknown), Daniël H. van Raalte	0
2	Exposure–Response Analysis of the Sodium–Glucose Cotransporter-2 Inhibitors Dapagliflozin and Empagliflozin on Kidney Hemodynamics in Patients with Type 2 Diabetes 2023 ·Journal of Personalized Medicine ·(unknown), (unknown), Erik J.M. van Bommel, (unknown), (unknown), Anne C. Hesp, Jasper Stevens, Daniël H. van Raalte, Hiddo J.L. Heerspink	0
3	Sodium glucose cotransporter-2 inhibitors protect the cardiorenal axis: Update on recent mechanistic insights related to kidney physiology 2022 ·European Journal of Internal Medicine ·Charlotte C. van Ruiten, Anne C. Hesp, Daniël H. van Raalte	6
4	The Adaptive Renal Response for Volume Homeostasis During 2 Weeks of Dapagliflozin Treatment in People With Type 2 Diabetes and Preserved Renal Function on a Sodium-Controlled Diet 2022 ·Kidney International Reports ·(unknown), Marcel H.A. Muskiet, (unknown), Anne C. Hesp, Peter J. Greasley, Ann Hammarstedt, Cecilia Karlsson, Karen Melissa Hallow, A.H. Jan Danser, Hiddo J.L. Heerspink, Daniël H. van Raalte	22
5	Mechanisms underlying the blood pressure‐lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes: A secondary analysis of a randomized crossover trial 2022 ·Diabetes Obesity and Metabolism ·(unknown), (unknown), Anne C. Hesp, Mark M. Smits, Hiddo J.L. Heerspink, Daniël H. van Raalte	8
6	Skin microvascular function and renal hemodynamics in overweight patients with type 2 diabetes: A cross‐sectional study 2021 ·Microcirculation ·(unknown), Mark M. Smits, Erik J.M. van Bommel, Marcel H.A. Muskiet, Anne C. Hesp, Erik H. Serné, Jaap A. Joles, Daniël H. van Raalte	1
7	Natriuretic Effect of Two Weeks of Dapagliflozin Treatment in Patients With Type 2 Diabetes and Preserved Kidney Function During Standardized Sodium Intake: Results of the DAPASALT Trial 2020 ·Diabetes Care ·(unknown), Marcel H.A. Muskiet, (unknown), Anne C. Hesp, Peter J. Greasley, Cecilia Karlsson, Ann Hammarstedt, Niki Arya, Daniël H. van Raalte, Hiddo J.L. Heerspink	87
8	Poor Taste and Smell Are Associated with Poor Appetite, Macronutrient Intake, and Dietary Quality but Not with Undernutrition in Older Adults 2020 ·Journal of Nutrition ·(unknown), Anne C. Hesp, (unknown), Max Nieuwdorp, Bart J. F. Keijser, Richard G. IJzerman, Marjolein Visser	41
9	The role of renal hypoxia in the pathogenesis of diabetic kidney disease: a promising target for newer renoprotective agents including SGLT2 inhibitors? 2020 ·Kidney International ·Anne C. Hesp, Jennifer A. Schaub, Pottumarthi V. Prasad, Volker Vallon, Gozewijn D. Laverman, Petter Bjornstad, Daniël H. van Raalte	132

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact